CONVERSION OF ATRIAL FIBRILLATION WITH ANTAZOLINE HYDROCHLORIDE (ARITHMIN)
- Identification of Hemodynamic Compromise by Cerebrovascular Reserve and Oxygen Extraction Fraction in Occlusive Vascular Disease. Nemoto, Edwin M.; Yonas, Howard; Kuwabara, Hiroto; Pindzola, Ronda R.; Sashin, Donald; Meltzer, Carolyn C.; Price, Julie C.; Yuefang Chang; Johnson, David W. // Journal of Cerebral Blood Flow & Metabolism;Oct2004, Vol. 24 Issue 10, p1081
SummaryCerebrovascular reserve (CVR) and oxygen extraction fraction (OEF) are used to identify hemodynamic compromise in symptomatic patients with carotid occlusive vascular disease, but evidence suggests that they are not equivalent. The authors studied the relationship between CVR and OEF to...
- From rags to riches: the atrial fibrillation story. Delamothe, Tony // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;6/9/2012, Vol. 344 Issue 7860, p30
The author discusses the availability of treatment options available for atrial fibrillation (AF). He cites the heart rhythm week organized by the ArrythmiaAlliance and the National Institute for Health and Clinical Excellence in which attending physicians recommend rivaroxaban as stroke...
- DU-176b equivalent to warfarin in non-valvular AF. Key, Nigel // Hem/Onc Today;12/25/2008, Vol. 9 Issue 23, p28
The article presents the results of a phase-2 study on the use of a once daily dose of DU-176b, an oral Factor Xa inhibitor, as an alternative treatment with warfarin in patients with atrial fibrillation (AF). According to the study, a once daily dose of DU-176b may be a safe alternative...
- Apixaban: treatment to prevent stroke. // Nursing & Residential Care;May2013, Vol. 15 Issue 5, p249
No abstract available.
- What's New In... ATRIAL FIBRILLATION: Is dronedarone more effective than amiodarone? BUSHARDT, REAMER L.; JONES, KELLY W. // JAAPA: Journal of the American Academy of Physician Assistants (;Feb2011, Vol. 24 Issue 2, p56
The article presents a comparable analysis between dronedarone and amiodarone as effective treatments of atrial fibrillation (AF). It compares the safety of amiodarone and dronedarone based on the potential for proarrhythmia, mortality rate, and other treatment-related adverse events. It...
- Drug-induced `Parkinson's' linked to Rxs. // Drug Topics;8/7/95, Vol. 139 Issue 15, p8
Reports on a study which investigated the frequency of drug-induced Parkinson's disease in an elderly population. Older people taking drugs for nervous disorders and dementia twice as likely as nonusers to develop symptoms that mimic Parkinson's disease.
- Physiologic study of the subthalamic volume. Zincone, A.; Landi, A.; Piolti, R.; Appollonio, I.; Mariani, C. B.; Pezzoli, G.; Gaini, S. M.; Frattola, L. // Neurological Sciences;Feb2001, Vol. 22 Issue 1, p111
Deep brain stimulation (DBS) obtains good control of advanced PD symptoms. Chronic stimulation of Stn may alleviate rigidity, dyskinesia and tremor. Anatomical and functional intraoperative mapping are mandatory to obtain careful target localisation. Per-operative macrostimulation was carried...
- PO-RR-069-S. // Physical Therapy;May1998, Vol. 78 Issue 5, pS24
Presents a summary of an article entitled `The Use of Marching Music to Affect Motor Block Characteristics in Parkinsonian Gait,' by T. Blahut, R. Crossen, S. Park, R. Rashleger and M. Moore.
- Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk. Haas, Sylvia; Bode, Christoph; Norrving, Bo; Turpie, Alexander G. G. // Vascular Health & Risk Management;2014, Vol. 10, p101
Rivaroxaban is a direct factor Xa inhibitor that is widely available to reduce the risk of stroke or systemic embolism in patients with nonvalvular atrial fibrillation and one or more risk factors for stroke. Rivaroxaban provides practical advantages compared with warfarin and other vitamin K...